Recruiting
Phase 2

A Study of Barzolvolimab in Patients with Prurigo Nodularis

Sponsor:

Celldex Therapeutics

Code:

NCT06366750

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

barzolvolimab

Matching Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information